FDA Investigator Myriam M Sosa

Myriam M Sosa has conducted inspections on 25 sites in 1 countries as of 18 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
25
Last Inspection Date:
18 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100006991
Countries of Inspections:
Puerto Rico
FDA Investigators that have inspected at least one site in common with Myriam M Sosa:
Abigail A Auster, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, An T Vu, Andrea George, PhD, Angelica M Hernandez, Annette Melendez, Ariel Cruz Figueroa, Arlene M Badillo, Arwa S El Hagrasy, Ashley N Queen, PhD, Binh T Nguyen, Brenda Rivera, Calvin B Koerner, Carlos A Medina, Cassandra L Abellard, CDR Ileana Barreto Pettit, Cheryl A Clausen, Christina Capacci Daniel, PhD, Christopher Downey, PhD, Colleen F Hoyt, Colleen Thomas, PhD, Daniel L Obrzut, Dayna I Martinez, Dell S Moller, Dennis Cantellops Paite, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna Christner, Dov H Pluznik, PhD, Dr. Carmelo Rosa, Dr. Zhihao Qiu (Peter), PhD, Edwin Martinez, Eliezar Ramos, Erika E Englund, PhD, Erika V Butler, Frances L Dejesus, Frederick L Fricke, German Rivera, Hector Espinet, Hector Jcolon Torres, Iraida Ortiz, Ivis L Negron, Javier O Vega, Jennifer Lalama, Jerri Baker, Joan M Cantellops Figueroa, Joe X Phillips, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Juan Rjimenez Garcia, Karl D Hezel, Krishna Ghosh, PhD, Laiza V Garcia, Lareese K Thomas, Laura E Garcia, Laurimer Kuilan Torres, Libia M Lugo, Lisa M Lopez, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Luis Soto Lopez, Margarita Santiago, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Marie A Fadden, Marie T Falcone, Marisol Faberlle, Marta E Gonzalez, Marybet Lopez Negron, Maxwell Van Tassell, PhD, Michael A Charles, Michael R Klapal, Michael Shanks, MS, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Hernandez Sanchez, Milva E Melendez Perales, Nancy Rosado, Neisa M Alonso, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul L Bellamy, Paul Z Balcer, Paula A Trost, Prabhu P Raju, Rafael E Cruz, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Rapti D Madurawe, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Robert Darius, Robert Jennings, Santos E Camara, Sharmista Chatterjee, Sixto M Mercado Rios, Sonia M Monges, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Thomas J Arista, Timothy Wadkin, PhD, Victor S Pacheco, Vilmary Negron Rodriguez, Wanda J Torres, Wendy G Tan, PhD, Yeissa Chabrier Rosello, Yifan Wang, Ying Zhang, Zachary L Stamm, Zhong Li, PhD

Myriam M Sosa's Documents

Publish Date Document Type Title
March, 2007 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2007-03-27
September, 2003 EIR Pfizer Pharmaceuticals LLC - EIR, 2003-09-29
December, 2003 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2003-12-02
January, 2006 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2006-01-23
March, 2003 EIR Amgen Manufacturing Limited LLC - EIR, 2003-03-28
June, 2006 EIR Janssen Ortho LLC - EIR, 2006-06-15
September, 2003 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2003-09-30
January, 2003 FDA 483 Response Patheon Puerto Rico, Inc. - Form 483R, 2003-01-29
January, 2003 EIR Patheon Puerto Rico, Inc. - EIR, 2003-01-24
June, 2003 EIR INyX USA, Ltd. - EIR, 2003-06-23
August, 2006 EIR AbbVie Ltd - EIR, 2006-08-11
July, 2004 FDA 483 Ortho Biologics LLC - Form 483, 2004-07-08
August, 2006 FDA 483 AbbVie Ltd - Form 483, 2006-08-11
June, 2003 FDA 483 INyX USA, Ltd. - Form 483, 2003-06-23
August, 2003 FDA 483 Pfizer Pharmaceutical Llc. - Form 483, 2003-08-12
March, 2003 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2003-03-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more